203 related articles for article (PubMed ID: 12543661)
1. Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin.
Reipert A; Ehlert K; Kast T; Bierbaum G
Antimicrob Agents Chemother; 2003 Feb; 47(2):568-76. PubMed ID: 12543661
[TBL] [Abstract][Full Text] [Related]
2. Production of capsular polysaccharide does not influence Staphylococcus aureus vancomycin susceptibility.
Jansen A; Szekat C; Schröder W; Wolz C; Goerke C; Lee JC; Türck M; Bierbaum G
BMC Microbiol; 2013 Mar; 13():65. PubMed ID: 23522028
[TBL] [Abstract][Full Text] [Related]
3. Role of the
G C B; Sahukhal GS; Elasri MO
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307991
[No Abstract] [Full Text] [Related]
4. Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus.
Jansen A; Türck M; Szekat C; Nagel M; Clever I; Bierbaum G
Int J Med Microbiol; 2007 Jul; 297(4):205-15. PubMed ID: 17418637
[TBL] [Abstract][Full Text] [Related]
5. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
Hort M; Bertsche U; Nozinovic S; Dietrich A; Schrötter AS; Mildenberger L; Axtmann K; Berscheid A; Bierbaum G
Microbiol Spectr; 2021 Oct; 9(2):e0052821. PubMed ID: 34668723
[TBL] [Abstract][Full Text] [Related]
6. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.
Cui L; Ma X; Sato K; Okuma K; Tenover FC; Mamizuka EM; Gemmell CG; Kim MN; Ploy MC; El-Solh N; Ferraz V; Hiramatsu K
J Clin Microbiol; 2003 Jan; 41(1):5-14. PubMed ID: 12517819
[TBL] [Abstract][Full Text] [Related]
7. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
[TBL] [Abstract][Full Text] [Related]
8. "Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.
Saito M; Katayama Y; Hishinuma T; Iwamoto A; Aiba Y; Kuwahara-Arai K; Cui L; Matsuo M; Aritaka N; Hiramatsu K
Antimicrob Agents Chemother; 2014 Sep; 58(9):5024-35. PubMed ID: 24841271
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan.
Hanaki H; Hososaka Y; Yanagisawa C; Otsuka Y; Nagasawa Z; Nakae T; Sunakawa K
J Infect Chemother; 2007 Apr; 13(2):118-21. PubMed ID: 17458681
[TBL] [Abstract][Full Text] [Related]
10. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
[TBL] [Abstract][Full Text] [Related]
11. Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain.
Di Gregorio S; Fernandez S; Cuirolo A; Verlaine O; Amoroso A; Mengin-Lecreulx D; Famiglietti A; Joris B; Mollerach M
Microb Drug Resist; 2017 Jan; 23(1):44-50. PubMed ID: 27991847
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
Ozmen Capin BB; Tekeli A; Karahan ZC
Microb Drug Resist; 2020 Mar; 26(3):238-244. PubMed ID: 31545160
[No Abstract] [Full Text] [Related]
13. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea.
Kim MN; Hwang SH; Pyo YJ; Mun HM; Pai CH
J Clin Microbiol; 2002 Apr; 40(4):1376-80. PubMed ID: 11923359
[TBL] [Abstract][Full Text] [Related]
14. Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.
Pfeltz RF; Singh VK; Schmidt JL; Batten MA; Baranyk CS; Nadakavukaren MJ; Jayaswal RK; Wilkinson BJ
Antimicrob Agents Chemother; 2000 Feb; 44(2):294-303. PubMed ID: 10639353
[TBL] [Abstract][Full Text] [Related]
15. walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.
Shoji M; Cui L; Iizuka R; Komoto A; Neoh HM; Watanabe Y; Hishinuma T; Hiramatsu K
Antimicrob Agents Chemother; 2011 Aug; 55(8):3870-81. PubMed ID: 21628539
[TBL] [Abstract][Full Text] [Related]
16. Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.
Hsueh PR; Lee SY; Perng CL; Chang TY; Lu JJ
Int J Antimicrob Agents; 2010 Oct; 36(4):307-12. PubMed ID: 20685086
[TBL] [Abstract][Full Text] [Related]
17. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate.
Boyle-Vavra S; Carey RB; Daum RS
J Antimicrob Chemother; 2001 Nov; 48(5):617-25. PubMed ID: 11679550
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureus.
Adhikari RP; Scales GC; Kobayashi K; Smith JM; Berger-Bächi B; Cook GM
J Antimicrob Chemother; 2004 Aug; 54(2):360-3. PubMed ID: 15243027
[TBL] [Abstract][Full Text] [Related]
19. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
Ghahremani M; Jazani NH; Sharifi Y
J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
[TBL] [Abstract][Full Text] [Related]
20. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.
Cui L; Tominaga E; Neoh HM; Hiramatsu K
Antimicrob Agents Chemother; 2006 Mar; 50(3):1079-82. PubMed ID: 16495273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
